[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351579-105":59,"doc-detail-351579-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-international-multi-centre-study-to-develop-and-validate-federated-learningbased-prognostic-models-for-anal-cancer-submitted-27-january-2025-accepted-20-february-2026","An international multi-centre study to develop and validate federated learningbased prognostic models for anal cancer - Submitted 27 January 2025 - Accepted 20 February 2026","","Precision oncology depends on high-quality data to support analyses in smaller patient subgroups. An international atomCAT consortium evaluates federated learning for rare cancers using anal cancer as an exemplar. Federated multivariable Cox models are trained across 14 centres and externally validated in two centres, showing consistent calibration and discrimination. Prognostic associations include T stage, nodal involvement, tumour volume, sex, age, and mitomycin- or cisplatin-based chemotherapy, supporting privacy-preserving collaboration without data sharing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-international-multi-centre-study-to-develop-and-validate-federated-learningbased-prognostic-models-for-anal-cancer-submitted-27-january-2025-accepted-20-february-2026/351579/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-international-multi-centre-study-to-develop-and-validate-federated-learningbased-prognostic-models-for-anal-cancer-submitted-27-january-2025-accepted-20-february-2026/351579.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What models were developed and how were they validated?","Question",{"text":112,"@type":113},"Federated multivariable Cox models were trained across 14 centres and externally validated in two additional centres, with performance assessed during leave-one-centre-out and external validation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which patient or treatment factors were linked to overall survival?",{"text":117,"@type":113},"Lower T stage, absence of nodal involvement, smaller tumour volume, female sex, younger age, and mitomycin- or cisplatin-based chemotherapy were associated with improved overall survival.",{"name":119,"@type":110,"acceptedAnswer":120},"How does federated learning help with rare cancer research?",{"text":121,"@type":113},"Federated learning enables robust prognostic modelling using real-world data while preserving patient privacy and allowing international collaboration without pooling data.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351579,1791403450,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article [https://doi.org/10.1038/s41467-026-70297-3](https://doi.org/10.1038/s41467-026-70297-3)  \nAn international multi-centre study to develop and validate federated learningbased prognostic models for anal cancer  \nReceived: 27 January 2025  \n\n| Accepted: 20 February 2026 |\n| --- |\n| |\n| Check for updates |\n\nStelios Theophanous 1,2 , Per-Ivar Lønne 3, Ananya Choudhury 4, Maaike Berbee4, Charlotte Deijen5,6, Andre Dekker 4, Matthew Field7,8,9,10, Maria Antonietta Gambacorta11, Alexandra Gilbert1,2,  \nMarianne Grønlie Guren 12,13, Rashmi Jadon14, Rohit Kochhar15,  \nDaniel Martin16,17,18, Ahmed Allam Mohamed19,20, Rebecca Muirhead 21,22, Oriol Parés 23, Łukasz Raszewski24, Rajarshi Roy25, Andrew Scarsbrook 1,2, David Sebag-Monteﬁore2, Emiliano Spezi 26, Vassilios Vassiliou27,  \nEirik Malinen28,34, Leonard Wee 4,34, Ane Appelt 1,2,34 & atomCAT Consortium*  \nPrecision oncology relies on access to high-quality data for increasingly smaller patient subgroups. The international atomCAT consortium investigates the potential of federated learning to support this, using anal cancer as a rare cancer exemplar. Here, we show that federated multivariable Cox models trained across 14 centres (1428 patients) and externally validated in two additional centres (277 patients) achieve consistent calibration and discrimination during leave-one-centre-out and external validation (c-indices 0.68-0.79). Lower T stage, absence of nodal involvement, smaller tumour volume, female sex, younger age, and mitomycin-or cisplatin-based chemotherapy are associated with improved overall survival. Lower T stage, smaller tumour volume, and female sex are associated with improved locoregional control, while absence of nodal involvement and smaller tumour volume are associated with better freedom from distant metastases. These ﬁndings demonstrate that federated learning enables robust, privacypreserving prognostic modelling for rare cancers using real-world data, supporting international collaboration without data sharing.  \nPrecision oncology has brought increasing use of molecular proﬁling and sub-stratiﬁcation, with more patients being treated with targeted agents guided by tumour genetic proﬁles. Consequently, many previously deemed ‘common cancers’ (e.g. lung cancer) can now be considered asa collection of rarer tumours. Therefore, rare cancers are diagnosed in an increasingly large proportion of patients1, and ultimately, all cancers are becoming rare cancers. This poses a key challenge for clinical trials and research: small patient numbers and wide geographic spread make it difﬁcult to generate evidence by standard  \nmethods2. Recruitment for large clinical trials is complicated and often impossible3, but traditional registry data do not have the depth needed for detailed subgrouping and analyses. Consequently, this constitutes a major barrier to research and development in an era of stratiﬁed medicine.  \nThere has been growing recognition of the signiﬁcant role of realworld data (RWD) in addressing the challenges related to rare cancer research. RWD can be broadly deﬁned as ‘data relating to patient health or experience or care delivery which is collected outside of  \nA full list of afﬁliations appears at the end of the paper. *A list of authors and their afﬁliations appears at the end of the paper.  \ne-mail: [stelios.theophanous@nhs.net](stelios.theophanous@nhs.net)  \nTable 1 | Patient and treatment characteristics of the primary and validation cohorts  \n\n|  |  | Primary cohort (14 centres) | Validation cohort (2 centres) |\n| --- | --- | --- | --- |\n| Number of patients |  | 1428 | 277 |\n| Treatment period |  | 2004–2022 | 2008–2023 |\n| Biological sex |  |  |  |\n|  | Male Female | 435 (30%) | 114 (41%) |\n|  |  | 993 (70%) | 163 (59%) |\n| Age at the start of radiotherapy (years) |  |  |  |\n|  | Mean | 62.4 | 61.0 |\n|  | (SD, range) | (11.3, 29–94) | 12.5 (21–92) |\n|  | Age \u003C50 | 197 (14%) | 52 (19%) |\n|  | Age 50–69 | 835 (58%) | 149 (54%) |\n|  | Age >=","cbCaiibvwVE1KOsf","https://ap.wps.com/l/cbCaiibvwVE1KOsf","pdf",1782133,13,"English","# Overview\n## Study setup and federated model validation\n## Clinical prognostic factors and outcomes","[{\"question\":\"What models were developed and how were they validated?\",\"answer\":\"Federated multivariable Cox models were trained across 14 centres and externally validated in two additional centres, with performance assessed during leave-one-centre-out and external validation.\"},{\"question\":\"Which patient or treatment factors were linked to overall survival?\",\"answer\":\"Lower T stage, absence of nodal involvement, smaller tumour volume, female sex, younger age, and mitomycin- or cisplatin-based chemotherapy were associated with improved overall survival.\"},{\"question\":\"How does federated learning help with rare cancer research?\",\"answer\":\"Federated learning enables robust prognostic modelling using real-world data while preserving patient privacy and allowing international collaboration without pooling data.\"}]","An international multi-centre study to develop and validate federated learningbased prognostic models for anal cancer - Submitted 27 January 2025 - Accepted 20 February 2026 | PDF",1790094797,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68463b54214a0570924f564f2034e653.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac83b2dc2345b069d44e5e64bcfd903c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e207115e791c0486cb2bd86f8f7fc790.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07a00c7f526c6750ff6f602d214e0acc.webp",980,1301]